Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.8 USD | -0.22% | -11.60% | +28.97% |
May. 20 | Immunome Completes Purchase of Antibodies From Atreca | MT |
May. 20 | Immunome, Inc. completed the acquisition of Substantially all Assets of Atreca, Inc.. | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.97% | 827M | |
+9.58% | 115B | |
+12.41% | 107B | |
-3.58% | 21.6B | |
-12.38% | 22.31B | |
-6.77% | 19.19B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B |
- Stock Market
- Equities
- IMNM Stock
- News Immunome, Inc.
- JPMorgan Starts Immunome With Overweight Rating, $24 Price Target